Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-14 4:08 pm Sale | 2024-12-31 | 13G | Forian Inc. FORA | Larry N. Feinberg | 1,366,107 4.400% | -453,420![]() (-24.92%) | Filing History |
2024-02-13 4:15 pm Purchase | 2023-12-31 | 13G | Forian Inc. FORA | Larry N. Feinberg | 1,819,527 5.790% | 31,417![]() (+1.76%) | Filing History |
2023-02-09 5:29 pm Purchase | 2022-12-31 | 13G | Forian Inc. FORA | Larry N. Feinberg | 1,788,110 5.420% | 81,768![]() (+4.79%) | Filing History |
2022-04-14 4:05 pm Purchase | 2022-04-04 | 13G | Forian Inc. FORA | Larry N. Feinberg | 1,706,342 5.170% | 1,706,342![]() (New Position) | Filing History |
2022-02-24 4:20 pm Sale | 2022-02-18 | 13G | Pacific Biosciences of California, Inc. PACB | Larry N. Feinberg | 3,257,503 4.970% | -370,046![]() (-10.20%) | Filing History |
2022-02-11 4:05 pm Sale | 2021-12-31 | 13G | Agenus Inc. AGEN | Larry N. Feinberg | 463,957 3.550% | -139,921![]() (-23.17%) | Filing History |
2022-02-11 4:04 pm Sale | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Larry N. Feinberg | 3,627,549 5.530% | -178,590![]() (-4.69%) | Filing History |
2021-12-29 4:28 pm Sale | 2021-12-22 | 13G | Motus GI Holdings, Inc. MOTS | Larry N. Feinberg | 353 0.220% | -12,336![]() (-97.22%) | Filing History |
2021-11-24 4:05 pm Sale | 2021-11-17 | 13D | Aspira Women's Health Inc. AWH | Larry N. Feinberg | 369,807 4.950% | -237,221![]() (-39.08%) | Filing History |
2021-08-03 4:28 pm Sale | 2021-07-28 | 13G | Capricor Therapeutics, Inc. CAPR | Larry N. Feinberg | 0 0.000% | -2,000,000![]() (Position Closed) | Filing History |
2021-02-16 4:03 pm Sale | 2020-12-31 | 13G | QuidelOrtho Corporation QDEL | Larry N. Feinberg | 1,879,121 4.470% | -914,663![]() (-32.74%) | Filing History |
2021-02-16 4:03 pm Unchanged | 2020-12-31 | 13G | Motus GI Holdings, Inc. MOTS | Larry N. Feinberg | 12,689 9.460% | 0 (Unchanged) | Filing History |
2021-02-16 4:02 pm Sale | 2020-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Larry N. Feinberg | 248,843 4.700% | -131,160![]() (-34.52%) | Filing History |
2021-02-16 4:02 pm Sale | 2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | Larry N. Feinberg | 3,806,139 6.670% | -890,513![]() (-18.96%) | Filing History |
2021-02-16 4:01 pm Sale | 2020-12-31 | 13G | Agenus Inc. AGEN | Larry N. Feinberg | 603,878 6.230% | -57,784![]() (-8.73%) | Filing History |
2021-02-08 4:30 pm Purchase | 2021-01-29 | 13G | Capricor Therapeutics, Inc. CAPR | Larry N. Feinberg | 2,000,000 9.780% | 2,000,000![]() (New Position) | Filing History |
2021-02-04 5:13 pm Sale | 2021-01-29 | 13D | BIOLASE, Inc. BIOL | Larry N. Feinberg | 808 2.160% | -100![]() (-11.02%) | Filing History |
2020-08-19 10:08 am Sale | 2020-08-14 | 13D | Aspira Women's Health Inc. AWH | Larry N. Feinberg | 607,028 8.770% | -78,878![]() (-11.50%) | Filing History |
2020-07-30 7:37 pm Purchase | 2020-07-22 | 13G | Agenus Inc. AGEN | Larry N. Feinberg | 661,662 7.100% | 585,063![]() (+763.80%) | Filing History |
2020-06-11 7:17 pm Purchase | 2020-06-08 | 13D | Aspira Women's Health Inc. AWH | Larry N. Feinberg | 685,906 10.520% | 685,906![]() (New Position) | Filing History |